iMedicus

Upcoming Live Programs

View All (6)

Dispelling myths in AF: Managing the challenges of elderly, frail and/or renally impaired patients

Quelles sont les considerations de traiter la coronopathie au-delà de l'AAS? Est-ce le temps d'établir un nouveau standard?

Outils et technologies utiles en télémédecine pour le diagnostic et le suivi des patients avec FA durant la pandémie de COVID-19

Dispelling Misperceptions in AF: Managing the challenges of renally impaired patients

Managing Both the High-Risk CAD Patient and the Frail, Renally-Impaired AF Patient: What you need to know

Managing the Elderly, Frail and Renal AF Patient: What we need to know

On-Demand

View All (26)

An Approach to the Treatment of AF and CV Disease in These Challenging Times

How to Reduce the Risk of Major Cardiovascular and Limb Events in the CAD + PAD Patients

Prise en charge virtuelle des patients atteints de maladies cardiovasculaires pendant la pandémie de COVID

Hot Topics in Vascular Protection for the CAD Patient and AF Patient

Telemedicine in Today’s COVID-19 Reality: What GPs need to know

Virtual Management of Patients with AF and CV Disease During the COVID Pandemic

Breaking News: A Canadian perspective from ACC 2020

How to Manage the Risks of CV Events and Limb Events of the CAD+PAD Patient

How to Manage the Risks of CV Events and Limb Events of the CAD+PAD Patient

Les NACO chez les patients âgés et vulnérables : Que devrions-nous savoir?

February 13, 2020

Optimizing Heart Failure Therapy - The Time is Now: Putting Evidence into Practice

December 5, 2019

Deconstructing Cardiovascular Outcomes for Patients with Diabetes

December 5, 2019

Diabetes Mobile Apps: Benefits for Patients and Healthcare Professionals

November 13, 2019

The Evolving Landscape of Cutaneous Squamous Cell Carcinoma Treatment: Updates on Immunotherapy Treatment

October 30, 2019

15 min. Highlights from The Great Debate: Aspirin, DAPT or dual pathway inhibition for secondary prevention in stable ASCVD patients?

October 26, 2019

Women and CV Disease: Closing Care Gaps & Assessing Risk

Staying Ahead of the Disease: The Impact of a Proactive Approach to wAMD Management

Highlights from the Latest ODYSSEY OUTCOMES Data: The Role of PCSK9 Inhibition Post-ACS

February 21, 2019

Highlights from the Latest ODYSSEY OUTCOMES Data: The Role of PCSK9 Inhibition Post-ACS

February 13, 2019

Faits saillants des toutes dernières données de l’étude ODYSSEY OUTCOMES : Rôle de l’inhibition de la PCSK9 après un SCA

February 13, 2019

Traitement anticoagulant chez les patients atteints d’insuffisance rénale

November 14, 2018

Anticoagulation in Patients with Renal Impairment

October 10, 2018

Breaking News from ATS.18

Prise en charge de l’anticoagulothérapie prolongée dans les cas de TEV

Managing Extended Anticoagulant Therapy in VTE

Ask the Experts: Hot Topics in Heart Failure Management

Breaking News Series

View All (2)

Breaking News: A Canadian perspective from ACC 2020

Breaking News from ATS.18